Back
Exelon Corp. 10K Form
Buy
54
EXC
Exelon Corp.
Last Price:
$43.64
Seasonality Move:
2.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | EXC/Exelon Corp. Quarterly |
| 2024-02-21 | 10K | EXC/Exelon Corp. Annual |
| 2023-11-02 | 10Q | EXC/Exelon Corp. Quarterly |
| 2023-08-02 | 10Q | EXC/Exelon Corp. Quarterly |
| 2023-05-03 | 10Q | EXC/Exelon Corp. Quarterly |
| 2023-02-14 | 10K | EXC/Exelon Corp. Annual |
Receive EXC News And Ratings
See the #1 stock for the next 7 days that we like better than EXC
EXC Financial Statistics
Sales & Book Value
| Annual Sales: | $23B |
|---|---|
| Cash Flow: | $163M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $27.83 |
| Price / Book: | 1.57 |
Profitability
| EPS (TTM): | 2.79390 |
|---|---|
| Net Income (TTM): | $2.8B |
| Gross Margin: | $5.8B |
| Return on Equity: | 10.3% |
| Return on Assets: | 2.57% |
Exelon Corp. Earnings Forecast
Key Exelon Corp. Financial Ratios
-
The Gross Profit Margin over the past 45 years for EXC is 25.23%.
-
The Selling, General & Administrative Expenses for EXC have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 77.80% of Operating Income.
-
The Net Earning history of EXC is 10.68% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 20 years.
Exelon Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Electric Utilities |
| Sector: | Utilities |
| Current Symbol: | EXC |
| CUSIP: | 30161N |
| Website: | exeloncorp.com |
Debt
| Debt-to-Equity Ratio: | 1.79 |
|---|---|
| Current Ratio: | 0.94 |
| Quick Ratio: | 0.56 |
Price-to-Earnings
| Trailing P/E Ratio: | 17.8 |
|---|---|
| Forward P/E Ratio: | 15.35 |
EXC Technical Analysis vs Fundamental Analysis
Buy
54
Exelon Corp. (EXC)
is a Buy
Is Exelon Corp. a Buy or a Sell?
-
Exelon Corp. stock is rated a BuyThe current Exelon Corp. [EXC] share price is $43.66. The Score for EXC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.